Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Citric Acid BP EP USP Pharma Grade has shaped modern pharmaceutical and food production methods with its unique profile and high purity. Borne out of fermentation using specific strains of Aspergillus niger, the product finds its place not just as an acidulant but as a processing ingredient, stabilizer, and chelator. As a white, odorless, crystalline solid, Citric Acid Pharma Grade stands apart for its ability to meet strict standards outlined by British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) monographs. Assured quality means absence of contaminants like heavy metals, lead, or arsenic, and no traces of harmful toxic chemical residues that could put consumer safety at risk.
Molecularly, Citric Acid holds the formula C6H8O7, with a well-defined chemical structure consisting of three carboxyl groups and one hydroxyl group. Its structure ensures water solubility and a sour acidic taste, a reason why so many pharmaceutical products and food formulations depend on it for flavor adjustment and preservation. In its purest pharma grade, citric acid appears as translucent crystals, powder, or sometimes compact pearls, depending on the manufacturing process and downstream requirements. Bulk density settles in the range of 0.8 to 0.9 g/cm3. Melting point approaches 153°C, far above typical room conditions, highlighting its stability in solid state. In both powders and flakes, Citric Acid maintains homogeneity, essential for consistent dosing in clinical applications. The pH in a 1% aqueous solution hovers between 2.2 and 2.5 — a vital quality for maintaining controlled levels of acidity in formulations.
Product specifications stem from international compendia like BP, EP, and USP. They set limits on moisture (up to 0.5%), sulphated ash (a maximum of 0.05%), heavy metal contaminants (no more than 10 ppm), and bacterial content, which must be practically absent to safeguard end-user health. The material undergoes rigorous filtration and purification to ensure it remains free from microbials and pyrogens. In commerce, Citric Acid falls under the Harmonized System (HS) Code 2918.1400, used for tariff and customs purposes worldwide. Compliance with these standards gives clients peace of mind, whether they're blending the material into injectable drugs, pure electrolyte solutions, or food items.
Manufacturers deliver Citric Acid in granular, powdered, flaked, crystalline, and liquid forms. Each form fits a set of downstream applications. As a powder, pharmaceutical technicians find precise dosage comes easy, as product flows evenly and dissolves cleanly in both cold and warm solutions. In crystalline form, visibility helps for visual inspection during GMP processing, and many prefer this for solid dose formulations like chewable tablets or effervescent powders. Liquid citric acid supports injectable solutions, where particle-free compositions protect from embolism and ensure bioavailability. Supply chains must tackle packaging selection, since this acid leaches moisture and forms lumps if stored improperly. Keeping it in air-tight HDPE drums or triple-laminated bags reduces the spoilage risk, a small step in ensuring every kilogram reaches its destination with the original properties intact.
Production of Citric Acid starts with raw materials like corn or molasses. Fermentation delivers high yields with minimal waste, so long as feedstocks remain pure and genetically unmodified. Despite an excellent safety profile, citric acid deserves respect: concentrated solutions irritate eyes and open skin, and inhaling dust causes respiratory soreness. Safety Data Sheets recommend gloves and goggles during handling, ventilation in production rooms, and spill containment for larger volumes. Overexposure to citric acid does not typically lead to chronic health issues unless exposure reaches extreme concentrations. Classification as a weak organic acid means it avoids the hazardous label attached to stronger mineral acids, yet it remains best practice to use protective gear during loading, blending, or cleaning. Disposal must happen through dilution and controlled release, as concentrated citric acid can alter pH in wastewater streams and affect treatment plants.
One benefit stands out: its ability to bind calcium and other metal ions. This chelation property makes citric acid a staple in everything from anticoagulant solutions in blood banks to scale removal in kettles and cleaning agents. I have seen this material stabilize vitamin C tablets and keep canned vegetables bright and fresh for months. Citric acid’s non-toxic profile makes it a clear choice for food manufacturers who want to replace harsher acids without sacrificing shelf life. In labs and clinics, buffer action keeps pH where scientists want it, no matter the mixing or storage conditions, supporting everything from antibiotics to coronavirus vaccines. Its excellent solubility gives beverage makers the freedom to blend it easily into juices and soft drinks, raising both sourness and shelf stability.
Growing demand for citric acid in pharma and food sometimes triggers supply chain pressures, especially with raw material sourcing. Crop failures or geopolitical issues in grain-producing regions tend to ripple through the market, bumping up prices or stretching procurement lead times. To address interruptions, I’ve seen innovation through using more efficient fermentation strains or adapting waste-to-feedstock technologies that reuse agricultural byproducts. Controlling moisture during shipping draws attention too; keeping the air dry and monitoring humidity makes a tangible difference in maintaining powder free-flow and shelf life. Regulators continue to monitor and refine standards regarding presence of secondary residuals, aiming at protecting vulnerable groups: children, patients with chronic illnesses, and those on long-term medications. Solutions lie in transparency, regular onsite audits, and direct partnerships between users and manufacturers—building trust that can withstand market fluctuations and regulatory updates.
Chengguan District, Lanzhou, Gansu, China
